These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 27252269)

  • 21. IgG anti-beta(2) glycoprotein I antibodies in Malaysian patients with antiphospholipid syndrome and systemic lupus erythematosus: prevalence and clinical correlations.
    Ong SG; Cheng HM; Soon SC; Goh E; Chow SK; Yeap SS
    Clin Rheumatol; 2002 Sep; 21(5):382-5. PubMed ID: 12223986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement.
    Lopez LR; Simpson DF; Hurley BL; Matsuura E
    Ann N Y Acad Sci; 2005 Jun; 1051():313-22. PubMed ID: 16126973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analytical and clinical comparison of different immunoassay systems for the detection of antiphospholipid antibodies.
    Montaruli B; De Luna E; Erroi L; Marchese C; Mengozzi G; Napoli P; Nicolo' C; Romito A; Bertero MT; Sivera P; Migliardi M
    Int J Lab Hematol; 2016 Apr; 38(2):172-82. PubMed ID: 26847159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics of purified anti-β2GPI IgG N-glycosylation associate with thrombotic, obstetric and catastrophic antiphospholipid syndrome.
    Liu T; Han J; Zhang R; Tang Z; Yi G; Gong W; Wan L; Hu Q; Teng J; Liu H; Cheng X; Ye J; Su Y; Sun Y; Shi Y; Gu J; Ren S; Yang C; Shi H
    Rheumatology (Oxford); 2022 Mar; 61(3):1243-1254. PubMed ID: 34015111
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical value of anti-domain I-β2Glycoprotein 1 antibodies in antiphospholipid antibody carriers. A single centre, prospective observational follow-up study.
    Tonello M; Mattia E; Del Ross T; Favaro M; Calligaro A; Hoxha A; Bison E; Pengo V; Ruffatti A
    Clin Chim Acta; 2018 Oct; 485():74-78. PubMed ID: 29953850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the diagnostic potential of antibodies to beta2-glycoprotein 1 domain 1 in Chinese patients with antiphospholipid syndrome.
    Zhang S; Wu Z; Chen S; Li J; Wen X; Li L; Zhang W; Zhao J; Zhang F; Li Y
    Sci Rep; 2016 Apr; 6():23839. PubMed ID: 27053361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High IgA antiphospholipid autoantibodies in healthy Sudanese explain the increased prevalence among Sudanese compared to Swedish systemic lupus erythematosus patients.
    Elbagir S; Elshafie AI; Elagib EM; Mohammed NA; Aledrissy MI; Manivel VA; Pertsinidou E; Nur MA; Gunnarsson I; Svenungsson E; Rönnelid J
    Lupus; 2020 Oct; 29(11):1412-1422. PubMed ID: 32741301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Anti-beta2 glycoprotein I-beta2 glycoprotein I] immune complexes in patients with antiphospholipid syndrome and other autoimmune diseases.
    Biasiolo A; Rampazzo P; Brocco T; Barbero F; Rosato A; Pengo V
    Lupus; 1999; 8(2):121-6. PubMed ID: 10192506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atherogenic oxidized low-density lipoprotein/beta2-glycoprotein I (oxLDL/beta2GPI) complexes in patients with systemic lupus erythematosus and antiphospholipid syndrome.
    Matsuura E; Kobayashi K; Hurley BL; Lopez LR
    Lupus; 2006; 15(7):478-83. PubMed ID: 16898186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biosensor analysis of beta2-glycoprotein I-reactive autoantibodies: evidence for isotype-specific binding and differentiation of pathogenic from infection-induced antibodies.
    Metzger J; von Landenberg P; Kehrel M; Buhl A; Lackner KJ; Luppa PB
    Clin Chem; 2007 Jun; 53(6):1137-43. PubMed ID: 17434906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and Thrombotic Risk Assessment of Anti-β2 Glycoprotein I Domain I Antibodies: A Systematic Review.
    Radin M; Cecchi I; Roccatello D; Meroni PL; Sciascia S
    Semin Thromb Hemost; 2018 Jul; 44(5):466-474. PubMed ID: 28778105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The BH1 idiotype defines a population of anticardiolipin antibodies closely associated with the antiphospholipid syndrome.
    Mason AN; Harmer IJ; Mageed RA; Mackworth-Young CG
    Lupus; 1999; 8(3):234-9. PubMed ID: 10342717
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-β2GPI-domain I antibody is associated with extra-criteria manifestations in a large prospective antiphospholipid syndrome cohort in China.
    Zhou Y; Hu C; Qi W; Long Y; Huang C; Wang Q; Tian X; Zhao J; Li M; Zeng X
    Lupus Sci Med; 2023 Aug; 10(2):. PubMed ID: 37607781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of anti-β2-glycoprotein I/HLA-DR complex antibody with arterial thrombosis in female patients with systemic rheumatic diseases.
    Yoneda K; Ueda Y; Tanimura K; Arase H; Yamada H; Saegusa J
    Arthritis Res Ther; 2023 Oct; 25(1):195. PubMed ID: 37803443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Solid Phase Immunoassay for the Detection of Anti-β
    Willis R; Papalardo E; Nigel Harris E
    Methods Mol Biol; 2017; 1646():201-215. PubMed ID: 28804831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two Novel Technologies for the Detection of Anti-cardiolipin and Anti β2-Glycoprotein Antibodies in the Real Life: Chemiluminescent in Comparison to the Addressable Laser Bead Immunoassays.
    Grossi V; Infantino M; Benucci M; Li Gobbi F; Bandinelli F; Damiani A; Bodio C; Borghi MO; Mahler M; Aure MA; Bentow C; Manfredi M
    Immunol Invest; 2020 Feb; 49(1-2):58-68. PubMed ID: 31401900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An automated chemiluminescence immunoassay may detect mostly relevant IgG anticardiolipin antibodies according to revised Sydney criteria.
    Noubouossie D; Valsamis J; Corazza F; Rozen L; Debaugnies F; Demulder A
    Acta Clin Belg; 2012; 67(3):184-9. PubMed ID: 22897066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical performance of anticardiolipin and antiβ2 glycoprotein I antibodies using a new automated chemiluminescent assay: superior thrombotic prediction of combined results measured by two different methods.
    Chung Y; Kim JE; Lim HS; Kim HK
    Blood Coagul Fibrinolysis; 2014 Jan; 25(1):10-5. PubMed ID: 24158115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dual antibody reactivity to beta2-glycoprotein I and protein S: increased association with thrombotic events in the antiphospholipid syndrome.
    Erkan D; Zhang HW; Shriky RC; Merrill JT
    Lupus; 2002; 11(4):215-20. PubMed ID: 12043884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.